1. Home
  2. MYGN vs VSTS Comparison

MYGN vs VSTS Comparison

Compare MYGN & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.63

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$6.33

Market Cap

996.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
VSTS
Founded
1991
1936
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
625.5M
996.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MYGN
VSTS
Price
$6.63
$6.33
Analyst Decision
Buy
Sell
Analyst Count
12
4
Target Price
$11.82
$5.95
AVG Volume (30 Days)
928.8K
2.6M
Earning Date
02-23-2026
01-30-2026
Dividend Yield
N/A
0.51%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$825,300,000.00
$2,734,839,000.00
Revenue This Year
$0.08
N/A
Revenue Next Year
$5.28
$1.74
P/E Ratio
N/A
N/A
Revenue Growth
0.21
N/A
52 Week Low
$3.76
$3.98
52 Week High
$15.47
$16.68

Technical Indicators

Market Signals
Indicator
MYGN
VSTS
Relative Strength Index (RSI) 48.43 44.99
Support Level $6.09 $6.32
Resistance Level $6.85 $7.12
Average True Range (ATR) 0.27 0.40
MACD 0.02 -0.08
Stochastic Oscillator 49.33 22.60

Price Performance

Historical Comparison
MYGN
VSTS

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

Share on Social Networks: